Research output per year
Research output per year
Personal profile
Research interests
Sodium and water homeostasis, glycocalyx, hypertension, clinical pharmacology, tubulopathy, chronic kidney disease, hyponatremia, space physiology, renal stone disease
Specialisation
Sodium and water homeostasis, glycocalyx, hypertension, clinical pharmacology, tubulopathy, chronic kidney disease, hyponatremia
Education/Academic qualification
Medicine, Maastricht University
2006 → 2013
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
Dive into the research topics where Rik Olde Engberink is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Budget impact analysis of medication reviews by junior pharmacists in polypharmacy patients: a hospital perspective
Hectors, T., Kooijman, T., van Barreveld, M., Kuijvenhoven, M., Teeuwisse, P. & Olde Engberink, R., Oct 2026, In: International journal of clinical pharmacy. 48, 5, p. 2073-2081 9 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile -
Cystine-Binding Medication Is Poorly Accessible for the Treatment of Cystinuria
Peng, X., Penninx, B., Marsman, R. F., Capolongo, G., Courbebaisse, M., Knebelmann, B., Trepiccione, F., Emma, F., Servais, A., Hollak, C. E. M., Levtchenko, E. N. & Olde Engberink, R. H. G., 30 Jun 2026, In: Acta Cytol. 51, 1, p. 729-736 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile3 Downloads (Pure) -
Medications Influencing Serum Cystatin C Independent of Measured Glomerular Filtration Rate
Russel, W. A., Engberink, R. O., Creon, A., Caldinelli, A., Faucon, A.-L., Grams, M. E., Fu, E. L., Inker, L. A., Levey, A. S. & Carrero, J. J., 17 Apr 2026, (E-pub ahead of print) In: Journal of the American Society of Nephrology.Research output: Contribution to journal › Article › Academic › peer-review
-
Reducing variability in tissue sodium and potassium measurement: validation of microwave digestion for cardiovascular research
van Duin, R. E., Oppelaar, J. J., Heisel, A. G. U., Annor, A. A. K., Wouda, R. D., van Zuilen, K., Naessens, D. M. P., de Vos, J., Bakker, E. N. T. P., den Elzen, W. P. J., de Rotte, M., Olde Engberink, R. H. & Vogt, L., 1 Jan 2026, In: American Journal of Physiology. Heart and Circulatory Physiology. 330, 1, p. H51-H62Research output: Contribution to journal › Article › Academic › peer-review
Open AccessFile24 Downloads (Pure) -
Salt and chronic kidney disease
Murray, J., Marsman, R. F., Engberink, R. H. O. & Vogt, L., Aug 2026, In: Nature reviews. Nephrology. 22, 8, p. 522-540 19 p.Research output: Contribution to journal › Review article › Academic › peer-review
Activities
-
Hereditary Hypophosphatemic Rickets with Hypercalciuria
Olde Engberink, R. (Speaker)
2025Activity: Talk or presentation › Invited talk › Academic
-
Personalization of lifestyle and medical therapies: How to?
Olde Engberink, R. (Speaker)
2025Activity: Talk or presentation › Invited talk › Academic
-
Thiazide diuretics and skin cancer
Olde Engberink, R. (Speaker)
2025Activity: Talk or presentation › Invited talk › Academic
-
Estimation of Kidney Function with Cystatin C
Olde Engberink, R. (Speaker)
2025Activity: Talk or presentation › Invited talk › Academic
-
Baxdrostat and other aldosterone synthase inhibitors
Olde Engberink, R. (Speaker)
30 May 2024Activity: Talk or presentation › Invited talk › Academic
Prizes
-
-
-
-
-
ERA Eberhard Ritz Award for Young Investigators in clinical science
Olde Engberink, R. (Recipient), 2026
Prize: Honorary award › Academic
Press/Media
-
Salt substitutes significantly lower high blood pressure risk, study finds
12/02/2024
1 item of Media coverage
Press/Media: Press / Media
-
Waarschuwing EMA over bloeddrukverlager blijkt voorbarig
14/06/2023
1 item of Media coverage
Press/Media: Press / Media